LH Stock Ownership Activity

LABORATORY CRP OF AMER HLDGS 13F holders

4 value investing gurus have made changes to the LABORATORY CRP OF AMER HLDGS (LH) position according to the gurus' latest SEC quarterly report(s). LH has been bought (as a new position) by 1 guru(s), the number of LH shares has been increased by 1, decreased by 2 super investor(s).

Which gurus or hedge funds are buying LH now?

According to the latest SEC filing(s) LABORATORY CRP OF AMER HLDGS (LH) has been bought by 2 gurus: Daniel Loeb - Third Point (new buy) and John W. Rogers Jr. - Ariel Appreciation Fund (added shares +5.09%).

To see more about who is investing in LABORATORY CRP OF AMER HLDGS (LH), please go to the LH ownership page.

2022 Q4 (3 results)
Daniel Loeb
buy
+192,125
+0.76%
0.76%
Wallace Weitz
-2.33%
-2,500
-0.08%
3.33%
Paul Lountzis
-2.34%
-235
-0.03%
1.44%
Current price: $215.40 9.68% AVG reported price*: $238.48
2022 Q4 (1 result)
John W. Rogers Jr.
+5.09%
+8,483
+0.18%
3.62%
Current price: $215.40 8.53% Reported price*: $235.48
2022 Q3 (3 results)
Eric H. Schoenstein
-2.28%
-770
-0.00%
0.06%
Paul Lountzis
-2.51%
-258
-0.04%
1.39%
Wallace Weitz
-6.52%
-7,500
-0.22%
3.14%
Current price: $215.40 5.18% AVG reported price*: $204.80
2022 Q2 (5 results)
Eric H. Schoenstein
+8.12%
+2,540
+0.00%
0.07%
John W. Rogers Jr.
+6.62%
+10,339
+0.22%
3.56%
Paul Lountzis
-0.05%
-5
-0.00%
1.61%
Wallace Weitz
-8.00%
-10,000
-0.30%
3.48%
Ole Andreas Halvorsen
-100.00%
-727,287
-0.88%
0.00%
Current price: $215.40 8.09% AVG reported price*: $234.35
2022 Q1 (2 results)
Eric H. Schoenstein
+23.11%
+5,870
+0.01%
0.06%
Ole Andreas Halvorsen
-14.45%
-122,860
-0.13%
0.00%
Current price: $215.40 18.31% AVG reported price*: $263.67
2021 Q4 (5 results)
Charles Bobrinskoy
+16.08%
+1,401
+0.62%
4.48%
John W. Rogers Jr.
+13.90%
+19,067
+0.43%
3.51%
Ole Andreas Halvorsen
+7.38%
+58,401
+0.05%
0.77%
Eric H. Schoenstein
+3.72%
+910
+0.00%
0.06%
Paul Lountzis
-0.17%
-18
-0.00%
1.85%
Current price: $215.40 31.45% AVG reported price*: $314.21
2021 Q3 (5 results)
Eric H. Schoenstein
+21.42%
+4,320
+0.01%
0.05%
Charles Bobrinskoy
-20.09%
-2,190
-1.00%
3.98%
John W. Rogers Jr.
-21.61%
-37,810
-0.78%
2.83%
Ole Andreas Halvorsen
-42.35%
-581,668
-0.45%
0.61%
Mark A. Hillman
-100.00%
-18,000
-2.30%
0.00%
Current price: $215.40 23.46% AVG reported price*: $281.44
2021 Q2 (5 results)
Ole Andreas Halvorsen
+27.02%
+292,195
+0.24%
1.15%
Eric H. Schoenstein
+6.10%
+1,160
+0.00%
0.04%
Charles Bobrinskoy
+4.81%
+500
+0.21%
4.51%
John W. Rogers Jr.
-5.76%
-10,700
-0.21%
3.42%
Wallace Weitz
-16.67%
-25,000
-0.72%
3.62%
Current price: $215.40 21.91% AVG reported price*: $275.85
2021 Q1 (4 results)
Ole Andreas Halvorsen
+1,044.15%
+986,719
+0.75%
0.82%
Charles Bobrinskoy
+14.29%
+1,300
+0.54%
4.31%
Eric H. Schoenstein
+11.76%
+2,000
+0.00%
0.04%
Wallace Weitz
-9.09%
-15,000
-0.42%
4.18%
Current price: $215.40 15.54% AVG reported price*: $255.03
2020 Q4 (3 results)
Eric H. Schoenstein
+53.38%
+5,920
+0.01%
0.03%
John W. Rogers Jr.
+4.44%
+7,900
+0.14%
3.22%
Ole Andreas Halvorsen
-78.01%
-335,280
-0.19%
0.05%
Current price: $215.40 5.83% AVG reported price*: $203.54
2020 Q3 (6 results)
Ole Andreas Halvorsen
buy
+429,780
+0.29%
0.29%
Eric H. Schoenstein
+11.79%
+1,170
+0.00%
0.02%
Wallace Weitz
+10.00%
+15,000
+0.36%
3.92%
Paul Lountzis
-0.10%
-10
-0.00%
1.67%
Charles Bobrinskoy
-5.21%
-500
-0.21%
3.84%
John W. Rogers Jr.
-10.16%
-20,100
-0.39%
3.47%
Current price: $215.40 14.41% AVG reported price*: $188.26
2020 Q2 (5 results)
Paul Lountzis
buy
+10,322
+1.63%
1.63%
Eric H. Schoenstein
+18.38%
+1,540
+0.00%
0.02%
Charles Bobrinskoy
-9.43%
-1,000
-0.36%
3.47%
Wallace Weitz
-20.00%
-37,500
-0.85%
3.38%
John W. Rogers Jr.
-20.71%
-51,700
-0.90%
3.44%
Current price: $215.40 29.66% AVG reported price*: $166.12
47 of 76

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.